BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 24613540)

  • 21. A Commentary on a recent update of the ovarian cancer risk attributable to menopausal hormone therapy.
    Gompel A; Burger H
    Climacteric; 2015 Jun; 18(3):376-8. PubMed ID: 25812672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormonal management of migraine at menopause.
    Nappi RE; Sances G; Detaddei S; Ornati A; Chiovato L; Polatti F
    Menopause Int; 2009 Jun; 15(2):82-6. PubMed ID: 19465675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term use of hormone therapy for urogenital complaints: is there a role?
    Hendrix SL
    Med Clin North Am; 2003 Sep; 87(5):1029-37. PubMed ID: 14621329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone replacement therapy in postmenopausal women.
    Prelevic GM; Kocjan T; Markou A
    Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What happened to WHI: menopausal hormonal therapy in 2012.
    Hansen KA; Eyster KM
    Clin Obstet Gynecol; 2012 Sep; 55(3):706-12. PubMed ID: 22828102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternatives to hormone therapy: a clinical guide to menopausal transition.
    Davis RN
    Adv Nurse Pract; 2004 Oct; 12(10):37-8, 40, 42 passim. PubMed ID: 15518118
    [No Abstract]   [Full Text] [Related]  

  • 27. Risks and benefits of hormone replacement therapy, revisited. An update on the Women's Health Initiative study, which in 2002 changed the landscape of hormone replacement therapy.
    Duke Med Health News; 2014 Jan; 20(1):5-6. PubMed ID: 25632509
    [No Abstract]   [Full Text] [Related]  

  • 28. Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research.
    Henderson VW
    Neuroscience; 2006; 138(3):1031-9. PubMed ID: 16310963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Menopause, Estrogens, and Glucose Homeostasis in Women.
    Mauvais-Jarvis F
    Adv Exp Med Biol; 2017; 1043():217-225. PubMed ID: 29224097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 'timing hypothesis' for estrogen therapy in menopausal symptom management.
    Manson JE
    Womens Health (Lond); 2015 Jul; 11(4):437-40. PubMed ID: 26237097
    [No Abstract]   [Full Text] [Related]  

  • 31. Menopausal hormone therapy (MHT): refining our understanding of MHT research, optimally applying results, and considering the future of MHT.
    Anagnostis EA
    J Pharm Pract; 2012 Jun; 25(3):324-30. PubMed ID: 22550160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Options for the treatment of menopausal symptoms.
    Abernethy K
    Nurs Times; 2007 Mar 6-12; 103(10):28-9. PubMed ID: 17388148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Menopausal hormone therapy for vasomotor symptoms: balancing the risks and benefits with ultra-low doses of estrogen.
    Simon JA; Snabes MC
    Expert Opin Investig Drugs; 2007 Dec; 16(12):2005-20. PubMed ID: 18042008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of hormone replacement therapy on antithrombin III and protein C levels in menopausal women.
    Lacroix KA; Bean C; Reilly R; Curran-Celentano J
    Clin Lab Sci; 1997; 10(3):145-8. PubMed ID: 10167774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging facade of menopausal hormone therapy.
    Rees M
    Semin Reprod Med; 2010 Sep; 28(5):351-9. PubMed ID: 20845235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response.
    Hartsfield CL; Connelly MT; Newton KM; Andrade SE; Wei F; Buist DS
    J Natl Cancer Inst Monogr; 2005; (35):113-5. PubMed ID: 16287896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hormone replacement therapy of menopause. When to begin? When to stop?].
    Tabaste JL
    Contracept Fertil Sex; 1997 Apr; 25(4):285-7. PubMed ID: 9229518
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of personalized medicine in identifying appropriate candidates for menopausal estrogen therapy.
    Manson JE
    Metabolism; 2013 Jan; 62 Suppl 1():S15-9. PubMed ID: 23018143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular health and the menopausal woman: the role of estrogen and when to begin and end hormone treatment.
    Naftolin F; Friedenthal J; Nachtigall R; Nachtigall L
    F1000Res; 2019; 8():. PubMed ID: 31543950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knowledge and attitudes of health professionals regarding menopausal hormone therapies.
    Yeganeh L; Boyle J; Teede H; Vincent A
    Climacteric; 2017 Aug; 20(4):348-355. PubMed ID: 28379046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.